CUE

Cue Biopharma, Inc.$28.50+0.50 (+1.79%)

Prev Close$28.00·MCap$47.1M·P/E—·Vol109.7K·Yield—

▲

Buys (12M)

$599.7K

▼

Sells (12M)

$2.04M

◆

Net Activity

Net Seller

$1.44M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Cue Biopharma, Inc. (CUE) has been dominated by selling, with 2 insider purchases totaling $599.7K and 3 insider sales totaling $2.04M. The most recent insider transaction was by Meluzio Michael Vincent (officer: VP, Prin. Accounting Officer), who sold $169.3K worth of shares on Aug 17, 2026. Cue Biopharma, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $47.1M.

CUE Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Aug 17, 2026	Meluzio Michael Vincent	officer: VP, Prin. Accounting Officer	Sell	5,628	$30.09	$169.3K	53,070
Aug 17, 2026	Ray Sumita	officer, other: Chief Legal Compliance Officer	Sell	8,829	$30.09	$265.6K	124,991
Aug 14, 2026	Lin Shao-Lee	director, officer: Chief Executive Officer	Sell	58,258	$27.58	$1.61M2.2% OS	730,028
Jun 3, 2026	Lin Shao-Lee	director, officer: Chief Executive Officer	Buy	45,453	$11.00	$500.0K1.7% OS	45,453
Dec 30, 2025	Sarraf Pasha	Director	Buy	323,857	$0.31	$99.7K	0
Dec 16, 2024	PASSERI DANIEL R	CHIEF EXECUTIVE OFFICER	Buy	30,000	$1.03	$30.9K	0
Aug 25, 2023	Suri Anish	PRESIDENT AND CSO	Buy	4,000	$2.76	$11.0K	0
Aug 14, 2023	PASSERI DANIEL R	CHIEF EXECUTIVE OFFICER	Buy	3,000	$2.86	$8.6K	0
Mar 23, 2023	Kiener Peter A	Director	Sell	9,325	$3.28	$30.6K	0
Aug 21, 2022	Millar Kerri-Ann	CHIEF FINANCIAL OFFICER	Sell	2,828	$3.05	$8.6K	0
Jun 14, 2022	Gray Cameron	Director	Sell	112,673	$2.93	$330.0K	0
May 27, 2022	Morich Frank	Director	Buy	28,000	$3.75	$105.0K	0
May 23, 2022	Fletcher Aaron G.L.	Director	Buy	205,000	$3.47	$711.7K	0
Mar 31, 2022	Fletcher Aaron G.L.	Director	Buy	735,000	$4.76	$3.50M0.9% OS	0
Mar 31, 2022	PASSERI DANIEL R	CHIEF EXECUTIVE OFFICER	Sell	32,122	$4.88	$156.8K	0
Mar 31, 2022	Suri Anish	PRESIDENT AND CSO	Sell	7,068	$4.88	$34.5K	0
Nov 15, 2021	Kiener Peter A	Director	Sell	20,176	$17.93	$361.7K	0
Nov 15, 2021	Suri Anish	President and CSO	Sell	8,000	$18.05	$144.4K	0
Nov 11, 2021	Suri Anish	President and CSO	Sell	20,000	$15.07	$301.4K	0
Oct 3, 2021	Suri Anish	PRESIDENT AND CSO	Sell	14,134	$12.97	$183.3K	0
Sep 30, 2021	PASSERI DANIEL R	CHIEF EXECUTIVE OFFICER	Sell	31,677	$14.57	$461.5K	0
Sep 24, 2021	PASSERI DANIEL R	CHIEF EXECUTIVE OFFICER	Buy	3,400	$14.72	$50.1K	0
Sep 23, 2021	Suri Anish	PRESIDENT AND CSO	Sell	20,000	$15.23	$304.6K	0
Aug 23, 2021	Millar Kerri-Ann	CHIEF FINANCIAL OFFICER	Sell	1,251	$14.21	$17.8K	0
Mar 15, 2021	Pienta Kenneth	Chief Medical Officer	Sell	13,439	$15.10	$202.9K	0

CUE Insider Buying Activity

The following table shows recent insider purchases of Cue Biopharma, Inc. (CUE) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jun 3, 2026	Lin Shao-Lee	director, officer: Chief Executive Officer	Buy	45,453	$11.00	$500.0K1.7% OS	45,453
Dec 30, 2025	Sarraf Pasha	Director	Buy	323,857	$0.31	$99.7K	0
Dec 16, 2024	PASSERI DANIEL R	CHIEF EXECUTIVE OFFICER	Buy	30,000	$1.03	$30.9K	0
Aug 25, 2023	Suri Anish	PRESIDENT AND CSO	Buy	4,000	$2.76	$11.0K	0
Aug 14, 2023	PASSERI DANIEL R	CHIEF EXECUTIVE OFFICER	Buy	3,000	$2.86	$8.6K	0
May 27, 2022	Morich Frank	Director	Buy	28,000	$3.75	$105.0K	0
May 23, 2022	Fletcher Aaron G.L.	Director	Buy	205,000	$3.47	$711.7K	0
Mar 31, 2022	Fletcher Aaron G.L.	Director	Buy	735,000	$4.76	$3.50M0.9% OS	0
Sep 24, 2021	PASSERI DANIEL R	CHIEF EXECUTIVE OFFICER	Buy	3,400	$14.72	$50.1K	0

CUE Insider Selling Activity

The following table shows recent insider sales of Cue Biopharma, Inc. (CUE) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Aug 17, 2026	Meluzio Michael Vincent	officer: VP, Prin. Accounting Officer	Sell	5,628	$30.09	$169.3K	53,070
Aug 17, 2026	Ray Sumita	officer, other: Chief Legal Compliance Officer	Sell	8,829	$30.09	$265.6K	124,991
Aug 14, 2026	Lin Shao-Lee	director, officer: Chief Executive Officer	Sell	58,258	$27.58	$1.61M2.2% OS	730,028
Mar 23, 2023	Kiener Peter A	Director	Sell	9,325	$3.28	$30.6K	0
Aug 21, 2022	Millar Kerri-Ann	CHIEF FINANCIAL OFFICER	Sell	2,828	$3.05	$8.6K	0
Jun 14, 2022	Gray Cameron	Director	Sell	112,673	$2.93	$330.0K	0
Mar 31, 2022	PASSERI DANIEL R	CHIEF EXECUTIVE OFFICER	Sell	32,122	$4.88	$156.8K	0
Mar 31, 2022	Suri Anish	PRESIDENT AND CSO	Sell	7,068	$4.88	$34.5K	0
Nov 15, 2021	Kiener Peter A	Director	Sell	20,176	$17.93	$361.7K	0
Nov 15, 2021	Suri Anish	President and CSO	Sell	8,000	$18.05	$144.4K	0
Nov 11, 2021	Suri Anish	President and CSO	Sell	20,000	$15.07	$301.4K	0
Oct 3, 2021	Suri Anish	PRESIDENT AND CSO	Sell	14,134	$12.97	$183.3K	0
Sep 30, 2021	PASSERI DANIEL R	CHIEF EXECUTIVE OFFICER	Sell	31,677	$14.57	$461.5K	0
Sep 23, 2021	Suri Anish	PRESIDENT AND CSO	Sell	20,000	$15.23	$304.6K	0
Aug 23, 2021	Millar Kerri-Ann	CHIEF FINANCIAL OFFICER	Sell	1,251	$14.21	$17.8K	0
Mar 15, 2021	Pienta Kenneth	Chief Medical Officer	Sell	13,439	$15.10	$202.9K	0